Back to top

earnings-estimates-revisions: Archive

Zacks Equity Research

Is Disney (DIS) a Buy as Wall Street Analysts Look Optimistic?

The average brokerage recommendation (ABR) for Disney (DIS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

DISNegative Net Change

Zacks Equity Research

Earnings Estimates Moving Higher for Betterware de Mexico SAPI de C (BWMX): Time to Buy?

Betterware de Mexico SAPI de C (BWMX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

BWMXNegative Net Change

Zacks Equity Research

CryoPort (CYRX) Upgraded to Buy: Here's What You Should Know

CryoPort (CYRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CYRXNegative Net Change

Zacks Equity Research

Celestica (CLS) Upgraded to Buy: Here's Why

Celestica (CLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CLSNegative Net Change

Zacks Equity Research

All You Need to Know About Intellicheck Mobilisa (IDN) Rating Upgrade to Strong Buy

Intellicheck Mobilisa (IDN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

IDNPositive Net Change

Zacks Equity Research

BGSF (BGSF) Upgraded to Strong Buy: What Does It Mean for the Stock?

BGSF (BGSF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

BGSFPositive Net Change

Zacks Equity Research

Tokio Marine (TKOMY) Upgraded to Strong Buy: Here's Why

Tokio Marine (TKOMY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

TKOMYNegative Net Change

Zacks Equity Research

LifeStance Health (LFST) Upgraded to Strong Buy: What Does It Mean for the Stock?

LifeStance Health (LFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

LFSTNegative Net Change

Zacks Equity Research

Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know

Quest Diagnostics (DGX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

DGXNegative Net Change

Zacks Equity Research

Dorian LPG (LPG) Upgraded to Strong Buy: Here's Why

Dorian LPG (LPG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

LPGPositive Net Change

Zacks Equity Research

Mitsubishi (MSBHF) Upgraded to Strong Buy: What Does It Mean for the Stock?

Mitsubishi (MSBHF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

MSBHFPositive Net Change

Zacks Equity Research

All You Need to Know About Paysafe Limited (PSFE) Rating Upgrade to Strong Buy

Paysafe Limited (PSFE) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PSFENegative Net Change

Zacks Equity Research

Wall Street Analysts See a 34.26% Upside in MongoDB (MDB): Can the Stock Really Move This High?

The consensus price target hints at a 34.3% upside potential for MongoDB (MDB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

MDBNegative Net Change

Zacks Equity Research

Wall Street Analysts Think Quanex (NX) Could Surge 95.46%: Read This Before Placing a Bet

The consensus price target hints at a 95.5% upside potential for Quanex (NX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

NXNegative Net Change

Zacks Equity Research

Brokers Suggest Investing in AGNC Investment (AGNC): Read This Before Placing a Bet

According to the average brokerage recommendation (ABR), one should invest in AGNC Investment (AGNC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

AGNCNegative Net Change

Zacks Equity Research

Is It Worth Investing in Veeva (VEEV) Based on Wall Street's Bullish Views?

According to the average brokerage recommendation (ABR), one should invest in Veeva (VEEV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

VEEVNegative Net Change

Zacks Equity Research

Is JD.com (JD) a Buy as Wall Street Analysts Look Optimistic?

The average brokerage recommendation (ABR) for JD.com (JD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

JDNegative Net Change

Zacks Equity Research

Is It Worth Investing in CyberArk (CYBR) Based on Wall Street's Bullish Views?

Based on the average brokerage recommendation (ABR), CyberArk (CYBR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

CYBRPositive Net Change

Zacks Equity Research

MongoDB (MDB) Is Considered a Good Investment by Brokers: Is That True?

The average brokerage recommendation (ABR) for MongoDB (MDB) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

MDBNegative Net Change

Zacks Equity Research

Wall Street Bulls Look Optimistic About GigaCloud Technology Inc. (GCT): Should You Buy?

According to the average brokerage recommendation (ABR), one should invest in GigaCloud Technology Inc. (GCT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

GCTNegative Net Change

Zacks Equity Research

Brokers Suggest Investing in PDD Holdings Inc. Sponsored ADR (PDD): Read This Before Placing a Bet

Based on the average brokerage recommendation (ABR), PDD Holdings Inc. Sponsored ADR (PDD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

PDDPositive Net Change

Zacks Equity Research

Is CRISPR Therapeutics (CRSP) a Buy as Wall Street Analysts Look Optimistic?

Based on the average brokerage recommendation (ABR), CRISPR Therapeutics (CRSP) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

CRSPNegative Net Change

Zacks Equity Research

Wall Street Bulls Look Optimistic About Dorian LPG (LPG): Should You Buy?

According to the average brokerage recommendation (ABR), one should invest in Dorian LPG (LPG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

LPGPositive Net Change

Zacks Equity Research

Should You Invest in Zoetis (ZTS) Based on Bullish Wall Street Views?

The average brokerage recommendation (ABR) for Zoetis (ZTS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

ZTSNegative Net Change

Zacks Equity Research

Compared to Estimates, Nike (NKE) Q4 Earnings: A Look at Key Metrics

Although the revenue and EPS for Nike (NKE) give a sense of how its business performed in the quarter ended May 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

NKEPositive Net Change